Literature DB >> 20882609

Quantitative cerebral MR perfusion imaging: preliminary results in stroke.

Maulin K Shah1, Wanyong Shin, Vishal S Parikh, Ann Ragin, Jessy Mouannes, Richard A Bernstein, Matthew T Walker, Hem Bhatt, Timothy J Carroll.   

Abstract

PURPOSE: To evaluate quantitative cerebral blood flow (qCBF) with traditional time-based measurements or metrics of cerebral perfusion: time to peak (Tmax) and mean transit time (MTT) in stroke patients.
MATERIALS AND METHODS: Nine ischemic stroke patients (four male, five female, 63 ± 16 years old) were included in the study which was Health Insurance Portability and Accountability Act compliant and institutional review board approved. Cerebral perfusion was quantified using the Bookend method. Mean values of qCBF, Tmax, and MTT were determined in regions of interest (ROIs). ROIs were drawn on diffusion weighted images in diffusion positive, critically ischemic (CI), in ipsilateral normal region immediately surrounding the critically ischemic region, the presumed penumbra (PP), and in contralateral diffusion negative control, presumed normal region (PN) of gray and white matter separately (GM and WM).
RESULTS: In both GM and WM, qCBF measures distinguished the studied brain regions with the most markedly reduced values in regions corresponding to extent of likely ischemic injury. In planned comparisons, only qCBF measurements differed significantly between CI and PP tissues. ROC analysis supported the utility of qCBF for discriminating brain regions differing in the likely extent of ischemic injury (CI and PN regions - qCBF: area under the curve [AUC] = 0.96, Tmax: AUC = 0.96, MTT: AUC = 0.72). Importantly, qCBF afforded the best discrimination of CI and PP regions (qCBF: AUC = 0.82, Tmax: AUC = 0.65, MTT: AUC = 0.52).
CONCLUSION: This initial evaluation indicates that quantitative MRI perfusion is feasible in ischemic stroke patients. qCBF derived with this strategy provide enhanced discrimination of CI and PP compared to time-based imaging metrics. This approach merits investigation in larger clinical studies.

Entities:  

Mesh:

Year:  2010        PMID: 20882609      PMCID: PMC2951630          DOI: 10.1002/jmri.22302

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  41 in total

1.  Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling.

Authors:  J A Chalela; D C Alsop; J B Gonzalez-Atavales; J A Maldjian; S E Kasner; J A Detre
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

2.  Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow.

Authors:  D C Alsop; J A Detre
Journal:  J Cereb Blood Flow Metab       Date:  1996-11       Impact factor: 6.200

3.  Incidence and occurrence of total (first-ever and recurrent) stroke.

Authors:  G R Williams; J G Jiang; D B Matchar; G P Samsa
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

4.  Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study.

Authors:  W Lin; A Celik; C Derdeyn; H An; Y Lee; T Videen; L Ostergaard; W J Powers
Journal:  J Magn Reson Imaging       Date:  2001-12       Impact factor: 4.813

5.  Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke.

Authors:  Michael D Hill; Philip A Barber; Andrew M Demchuk; Nancy J Newcommon; Andrea Cole-Haskayne; Karla Ryckborst; Laurel Sopher; Allison Button; William Hu; Mark E Hudon; William Morrish; Richard Frayne; Robert J Sevick; Alastair M Buchan
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

6.  Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient.

Authors:  L Røhl; L Ostergaard; C Z Simonsen; P Vestergaard-Poulsen; G Andersen; M Sakoh; D Le Bihan; C Gyldensted
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

7.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.

Authors:  C S Kidwell; J L Saver; J Mattiello; S Starkman; F Vinuela; G Duckwiler; Y P Gobin; R Jahan; P Vespa; M Kalafut; J R Alger
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

8.  Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging.

Authors:  O Wu; W J Koroshetz; L Ostergaard; F S Buonanno; W A Copen; R G Gonzalez; G Rordorf; B R Rosen; L H Schwamm; R M Weisskoff; A G Sorensen
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

9.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

10.  Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

Authors:  Werner Hacke; Anthony J Furlan; Yasir Al-Rawi; Antoni Davalos; Jochen B Fiebach; Franz Gruber; Markku Kaste; Leslie J Lipka; Salvador Pedraza; Peter A Ringleb; Howard A Rowley; Dietmar Schneider; Lee H Schwamm; Joaquin Serena Leal; Mariola Söhngen; Phil A Teal; Karin Wilhelm-Ogunbiyi; Max Wintermark; Steven Warach
Journal:  Lancet Neurol       Date:  2008-12-25       Impact factor: 44.182

View more
  8 in total

1.  Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat.

Authors:  Ajmal Ahmad; Mohd Moshahid Khan; Hayate Javed; Syed Shadab Raza; Tauheed Ishrat; M Badruzzaman Khan; Mohammed M Safhi; Fakhrul Islam
Journal:  Mol Cell Biochem       Date:  2012-05-22       Impact factor: 3.396

2.  Clinically relevant reperfusion in acute ischemic stroke: MTT performs better than Tmax and TTP.

Authors:  Andria L Ford; Hongyu An; Linglong Kong; Hongtu Zhu; Katie D Vo; William J Powers; Weili Lin; Jin-Moo Lee
Journal:  Transl Stroke Res       Date:  2014-02-06       Impact factor: 6.829

3.  Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.

Authors:  S-P Hojjat; M Kincal; R Vitorino; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-24       Impact factor: 3.825

4.  Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Authors:  R Vitorino; S-P Hojjat; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

5.  Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.

Authors:  A D Mulholland; R Vitorino; S-P Hojjat; A Y Ma; L Zhang; L Lee; T J Carroll; C G Cantrell; C R Figley; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2017-11-02       Impact factor: 3.825

6.  Magnetic resonance perfusion imaging evaluation in perfusion abnormalities of the cerebellum after supratentorial unilateral hyperacute cerebral infarction.

Authors:  Pan Liang; Yunjun Yang; Weijian Chen; Yuxia Duan; Hongqing Wang; Xiaotong Wang
Journal:  Neural Regen Res       Date:  2012-04-25       Impact factor: 5.135

7.  Dynamic susceptibility contrast 19 F-MRI of inhaled perfluoropropane: a novel approach to combined pulmonary ventilation and perfusion imaging.

Authors:  Mary A Neal; Benjamin J Pippard; A John Simpson; Peter E Thelwall
Journal:  Magn Reson Med       Date:  2019-08-29       Impact factor: 4.668

8.  Evaluation of infarct core and ischemic penumbra by absolute quantitative cerebral dynamic susceptibility contrast perfusion magnetic resonance imaging using self-calibrated echo planar imaging sequencing in patients with acute ischemic stroke.

Authors:  Xiaoyue Ma; Yan Wang; Mengke Wang; Menghuan Zhang; Nan Meng; Long Zhang; Jinlong Zhang; Shewei Dou; Meiyun Wang
Journal:  Quant Imaging Med Surg       Date:  2022-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.